Covered recipient · General Payments record
NEELU AGARWAL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,930.19
- Reported across 158 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $746.16 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $185.39 | 3 |
| Lilly USA, LLC | $124.29 | 7 |
| Novo Nordisk AS | $118.32 | 5 |
| ABBVIE INC. | $64.54 | 3 |
| Amgen Inc. | $59.55 | 4 |
| Radius Health, Inc. | $51.46 | 2 |
| MERZ NORTH AMERICA, INC. | $43.70 | 1 |
| Exact Sciences Corporation | $39.24 | 2 |
| Abbott Laboratories | $37.80 | 1 |
| PFIZER INC. | $21.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $37.80 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125179950 | CMS |
| ABBVIE INC. | $24.54 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103179272 | CMS |
| ABBVIE INC. | $16.22 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103179274 | CMS |
| ABBVIE INC. | $23.78 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103179276 | CMS |
| Amgen Inc. | $15.60 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115410595 | CMS |
| Amgen Inc. | $15.60 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115410604 | CMS |
| Amgen Inc. | $14.29 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117489862 | CMS |
| Amgen Inc. | $14.06 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115410600 | CMS |
| AstraZeneca Pharmaceuticals LP | $34.42 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104669713 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.72 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105706254 | CMS |
| AstraZeneca Pharmaceuticals LP | $128.25 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104645063 | CMS |
| Exact Sciences Corporation | $16.02 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114570324 | CMS |
| Exact Sciences Corporation | $23.22 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114570328 | CMS |
| Lilly USA, LLC | $20.67 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135276746 | CMS |
| Lilly USA, LLC | $20.78 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135240750 | CMS |
| Lilly USA, LLC | $13.90 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135244583 | CMS |
| Lilly USA, LLC | $14.78 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135240742 | CMS |
| Lilly USA, LLC | $17.32 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135240746 | CMS |
| Lilly USA, LLC | $13.53 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135276750 | CMS |
| Lilly USA, LLC | $23.31 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135244579 | CMS |
| MERZ NORTH AMERICA, INC. | $43.70 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146373690 | CMS |
| Novo Nordisk Inc | $16.68 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097786539 | CMS |
| Novo Nordisk Inc | $18.15 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096913326 | CMS |
| Novo Nordisk Inc | $48.41 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096569782 | CMS |
| Novo Nordisk Inc | $18.74 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096761441 | CMS |
| Novo Nordisk Inc | $16.34 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096700628 | CMS |
| PFIZER INC. | $21.87 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131638794 | CMS |
| Radius Health, Inc. | $33.79 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979465 | CMS |
| Radius Health, Inc. | $17.67 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979469 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.